ReviewCancer biology & medicine2026

First-line immunotherapy for advanced HER2-negative gastric cancer: differences between Asian and non-Asian patients.

Chuanhua Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.